SIROMED PHARMA, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
11,745,000 |
821,329 |
218,000 |
178,000 |
12,448 |
14.99 |
1.52 |
1,341,000 |
5,526,000 |
171,000 |
6,696,000 |
2023 |
---|
11,011,000 |
799,637 |
33,000 |
5,000 |
363 |
15.09 |
0.05 |
1,346,000 |
6,104,000 |
147,000 |
7,303,000 |
2024 |
---|
11,422,000 |
875,249 |
167,000 |
126,000 |
9,655 |
15.74 |
1.10 |
1,472,000 |
5,429,000 |
252,000 |
6,649,000 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
11,422,000 €4 % *
Sales per employee (€)
875,249 €9 % *
Profit before tax (€)
167,000 €406 % *
Net Profit (€)
126,000 €2,420 % *
Profit per employee (€)
9,655 €2,560 % *
Total profitability (%)
15.74 %4.31 % *
Net profitability (%)
1.10 %2,100.00 % *
Equity (€)
1,472,000 €9 % *
Amounts Payable And Liabilities (€)
5,429,000 €-11 % *
Non-current Assets (€)
252,000 €71 % *
CurrentAssets (€)
6,649,000 €-9 % *